在尼泊尔,胃肠道癌药物的可用性,负担能力和价格变化
Ramila Shilpakar1, Brian Shkabari2, Bibek Acharya1
1Department of Clinical Oncology, National Academy of Medical Sciences, Bir Hospital, Kathmandu, Nepal.
JCO global oncology
|November 13, 2025
概括
尼泊尔的胃肠道 (GI) 癌症药物的获取严重受限,因为供应量低,价格波动高. 大多数治疗是负担不起的,超过国家人均GDP,突出了关键的获取差距.
科学领域:
- 在瘤学瘤学.
- 卫生经济学 卫生经济学
- 制药政策 制药政策
背景情况:
- 获得癌症药物对于患者的治疗结果至关重要.
- 在尼泊尔,自付费用限制了患者获得癌症治疗的机会.
- 药物的有限可用性和负担能力是关键障碍.
研究的目的:
- 评估尼泊尔公共癌症医院的胃肠道 (GI) 癌症药物的可用性和负担能力.
- 检查不同机构对这些必要的癌症药物的价格变化.
主要方法:
- 在尼泊尔的四个公共癌症医院 (2022年10月至2023年1月) 进行了横截面调查.
- 分析了26种胃肠道癌治疗方案的可用性,可负担性和价格变化.
- 通过将每月治疗费用与尼泊尔人均GDP进行比较来确定可负担性.
主要成果:
- 只有53.8%的治疗方案至少在一家医院提供;34.6%的治疗方案在四家医院都有.
- 观察到显著的价格差异,capecitabine显示高达422%的医院内差异和irinotecan的997%的医院间差异.
- 大多数可用的胃肠道癌症治疗方法超过了人均月均GDP,这使得大多数患者无法负担得起.
结论:
- 尼泊尔的胃肠道癌症药物获取受到供应不良和价格差异严重的阻碍.
- 医院内部和医院内部的价格变化可能会导致患者的财务毒性和后勤负担.
- 迫切需要价格监管,透明度和本地制造,以确保公平获得癌症药物.
更多相关视频
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
11.5K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.6K
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
170
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
170
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
543
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
543
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:26Pharmaceutical Equivalents
171
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
171